TrialCancer gene therapy2006

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.

K Cornetta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.